Search research articles
Contact Us
Filters
Showing results (131-140 of 232) with videos related to
Page
of 24
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
Michael P Hudson, Paul W Armstrong, William W O'Neil, et al.
American Heart Journal
|
November 7, 2015
Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial
Warren J Cantor, Shamir R Mehta, Fei Yuan, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 17, 2012
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights
Sean van Diepen, Petr Widimsky, Renato D Lopes, et al.
JACC. Cardiovascular Interventions
|
March 26, 2013
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program
Sigmund Silber, Patrick W Serruys, Martin B Leon, et al.
Circulation
|
February 6, 2008
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
, Eric Bates, Christoph Bode, et al.
Journal of the American College of Cardiology
|
April 25, 2015
Reply: Not All NSTEMIs Are Created Equal
Gilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Journal of Cardiology
|
December 20, 2021
The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study
Milan Hromadka, Zuzana Motovska, Ota Hlinomaz, et al.
European Heart Journal
|
June 9, 2009
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
Renato D Lopes, Laine E Elliott, Harvey D White, et al.
Journal of the American College of Cardiology
|
December 20, 2014
Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study
Gilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
American Heart Journal
|
January 16, 2023
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial
Kelley R H Branch, Jeffrey L Probstfield, Jackie Bosch, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 232) with videos related to
Sort By:
Page
of 24
Circulation. Cardiovascular Quality and Outcomes
|
February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
Michael P Hudson, Paul W Armstrong, William W O'Neil, et al.
American Heart Journal
|
November 7, 2015
Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial
Warren J Cantor, Shamir R Mehta, Fei Yuan, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 17, 2012
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights
Sean van Diepen, Petr Widimsky, Renato D Lopes, et al.
JACC. Cardiovascular Interventions
|
March 26, 2013
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program
Sigmund Silber, Patrick W Serruys, Martin B Leon, et al.
Circulation
|
February 6, 2008
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
, Eric Bates, Christoph Bode, et al.
Journal of the American College of Cardiology
|
April 25, 2015
Reply: Not All NSTEMIs Are Created Equal
Gilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Journal of Cardiology
|
December 20, 2021
The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study
Milan Hromadka, Zuzana Motovska, Ota Hlinomaz, et al.
European Heart Journal
|
June 9, 2009
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
Renato D Lopes, Laine E Elliott, Harvey D White, et al.
Journal of the American College of Cardiology
|
December 20, 2014
Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study
Gilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
American Heart Journal
|
January 16, 2023
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial
Kelley R H Branch, Jeffrey L Probstfield, Jackie Bosch, et al.
Page
of 24